These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18019608)

  • 1. Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.
    Aziz NA; Swaab DF; Pijl H; Roos RA
    Rev Neurosci; 2007; 18(3-4):223-51. PubMed ID: 18019608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The hypothalamus in Huntington's disease].
    Bellosta-Diago E; Viloria-Alebesque A; Santos-Lasaosa S; Lopez Del Val LJ
    Rev Neurol; 2017 Nov; 65(9):415-422. PubMed ID: 29071701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Huntington's disease - new perspectives based on neuroendocrine changes in rodent models.
    Petersén A; Hult S; Kirik D
    Neurodegener Dis; 2009; 6(4):154-64. PubMed ID: 19521064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic and neuroendocrine changes in Huntington's disease.
    Hult S; Schultz K; Soylu R; Petersén A
    Curr Drug Targets; 2010 Oct; 11(10):1237-49. PubMed ID: 20594177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired hypothalamic endocrine function in neuroacanthocytosis.
    Kontoleon PE; Ilias I; Matsouka A; Gatzonis S; Spiropoulou C; Papapetrou PD
    J Clin Neurosci; 2003 Nov; 10(6):701-3. PubMed ID: 14592625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic alterations in Huntington's disease patients: comparison with genetic rodent models.
    van Wamelen DJ; Aziz NA; Roos RA; Swaab DF
    J Neuroendocrinol; 2014 Nov; 26(11):761-75. PubMed ID: 25074766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.
    Bellosta Diago E; Pérez Pérez J; Santos Lasaosa S; Viloria Alebesque A; Martínez Horta S; Kulisevsky J; López Del Val J
    Parkinsonism Relat Disord; 2017 Nov; 44():95-100. PubMed ID: 28935191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
    Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
    Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington's Disease.
    Kalliolia E; Silajdžić E; Nambron R; Costelloe SJ; Martin NG; Hill NR; Frost C; Watt HC; Hindmarsh P; Björkqvist M; Warner TT
    PLoS One; 2015; 10(10):e0138848. PubMed ID: 26431314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamic-endocrine aspects in Huntington's disease.
    Petersén A; Björkqvist M
    Eur J Neurosci; 2006 Aug; 24(4):961-7. PubMed ID: 16925587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothalamic and Limbic System Changes in Huntington's Disease.
    Petersén A; Gabery S
    J Huntingtons Dis; 2012; 1(1):5-16. PubMed ID: 25063186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Dysautonomia in Huntington's Disease.
    Abildtrup M; Shattock M
    J Huntingtons Dis; 2013; 2(3):251-61. PubMed ID: 25062674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease.
    Cheong RY; Gabery S; Petersén Å
    J Huntingtons Dis; 2019; 8(4):375-391. PubMed ID: 31594240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.
    Aziz NA; Anguelova GV; Marinus J; van Dijk JG; Roos RA
    Eur J Neurol; 2010 Aug; 17(8):1068-74. PubMed ID: 20192977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autonomic nervous function in Huntington's disease.
    Den Heijer JC; Bollen WL; Reulen JP; van Dijk JG; Kramer CG; Roos RA; Buruma OJ
    Arch Neurol; 1988 Mar; 45(3):309-12. PubMed ID: 2963605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Huntington's disease: the current state of research with peripheral tissues.
    Sassone J; Colciago C; Cislaghi G; Silani V; Ciammola A
    Exp Neurol; 2009 Oct; 219(2):385-97. PubMed ID: 19460373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleep deficits but no metabolic deficits in premanifest Huntington's disease.
    Lazar AS; Panin F; Goodman AO; Lazic SE; Lazar ZI; Mason SL; Rogers L; Murgatroyd PR; Watson LP; Singh P; Borowsky B; Shneerson JM; Barker RA
    Ann Neurol; 2015 Oct; 78(4):630-48. PubMed ID: 26224419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease.
    Aziz NA; Pijl H; Frölich M; van der Graaf AW; Roelfsema F; Roos RA
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1223-8. PubMed ID: 19174491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretin-1 and secondary signs in Huntington's disease.
    Roos RA; Aziz NA
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S387-90. PubMed ID: 18267269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of the HPG axis on stress response and depressive-like behaviour in a transgenic mouse model of Huntington's disease.
    Du X; Pang TY; Mo C; Renoir T; Wright DJ; Hannan AJ
    Exp Neurol; 2015 Jan; 263():63-71. PubMed ID: 25246229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.